Also, upregulating ALKBH5 expression sensitizes pancreatic ductal adenocarcinoma cells to chemotherapy treatment, indicating that ALKBH5 may play the same role in SCLC [30]. This evidence concerns the gene ALKBH5 and pancreatic ductal adenocarcinoma.